Binding of hepatic lipase to heparin: identification of specific heparin-binding residues in two distinct positive charge clusters

• Main Authors: Rebecca A. Sendak, Darlene E. Berryman, Gabrielle Gellman, Kristan Melford, Andre Bensadoun
• Format: Article
• Language: English
• Published: Elsevier 2000-02-01
• Series: Journal of Lipid Research
• Subjects: hepatic lipase; heparin binding domains; lipoprotein lipase; heparin sulfate proteoglycans; Chinese hamster ovary cells; heparin-Sepharose chromatography
• Online Access: http://www.sciencedirect.com/science/article/pii/S0022227520320605

The interaction of hepatic lipase (HL) with heparan sulfate is critical to the function of this enzyme. The primary amino acid sequence of HL was compared to that of lipoprotein lipase (LPL), a related enzyme that possesses several putative heparin-binding domains. Of the three putative heparin-binding clusters of LPL (J. Biol. Chem. 1994. 269: 4626–4633; J. Lipid Res. 1998. 39: 1310–1315), one was conserved in HL (Cluster 1; residues Lys 297–Arg 300 in rat HL) and two were partially conserved (Cluster 2; residues Asp 307–Phe 320, and Cluster 4; residues Lys 337, and Thr 432–Arg 443). Mutants of HL were generated in which potential heparin-binding residues within Clusters 1 and 4 were changed to Asn. Two chimeras in which the LPL heparin-binding sequences of Clusters 2 and 4 were substituted for the analogous HL sequences were also constructed. These mutants were expressed in Chinese hamster ovary (CHO) cells and assayed for heparin-binding ability using heparin-Sepharose chromatography and a CHO cell-binding assay. The results suggest that residues within the homologous Cluster 1 region (Lys 297, Lys 298, and Arg 300), as well as some residues in the partially conserved Cluster 4 region (Lys 337, Lys 436, and Arg 443), are involved in the heparin binding of hepatic lipase. In the cell-binding assay, heparan sulfate-binding affinity equal to that of LPL was seen for the RHL chimera mutant that possessed the Cluster 4 sequence of LPL. Mutation of Cluster 1 residues of HL resulted in a major reduction in heparin binding ability as seen in both the cell-binding assay and the heparin-Sepharose elution profile. These results suggest that Cluster 1, the N-terminal heparin-binding domain, is of primary significance in RHL. This is different for LPL: mutations in the C-terminal binding domain (Cluster 4) cause a more significant shift in the salt required for elution from heparin-Sepharose than mutations in the N-terminal domain (Cluster 1). —Sendak, R. A., D. E. Berryman, G. Gellman, K. Melford, and A. Bensadoun. Binding of hepatic lipase to heparin: identification of specific heparin-binding residues in two distinct positive charge clusters.